Celyad Sa Stock Shares Outstanding
| CYADDelisted Stock | USD 0.52 0.00 0.00% |
Celyad SA fundamentals help investors to digest information that contributes to Celyad SA's financial success or failures. It also enables traders to predict the movement of Celyad Stock. The fundamental analysis module provides a way to measure Celyad SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celyad SA stock.
Celyad |
Celyad SA Company Shares Outstanding Analysis
Celyad SA's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Celyad SA Shares Outstanding | 22.59 M |
Most of Celyad SA's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celyad SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Celyad SA has 22.59 M of shares currently outstending. This is 87.48% lower than that of the Biotechnology sector and 78.86% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 96.05% higher than that of the company.
Celyad Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Celyad SA's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Celyad SA could also be used in its relative valuation, which is a method of valuing Celyad SA by comparing valuation metrics of similar companies.Celyad SA is currently under evaluation in shares outstanding category among its peers.
Celyad Fundamentals
| Return On Equity | -1.71 | |||
| Return On Asset | -0.25 | |||
| Current Valuation | (1.57 M) | |||
| Shares Outstanding | 22.59 M | |||
| Shares Owned By Institutions | 29.16 % | |||
| Number Of Shares Shorted | 130.17 K | |||
| Price To Earning | (22.08) X | |||
| Price To Book | 0.69 X | |||
| Price To Sales | 12,738 X | |||
| Gross Profit | 5 K | |||
| EBITDA | (18.81 M) | |||
| Net Income | (40.94 M) | |||
| Cash And Equivalents | 14.38 M | |||
| Cash Per Share | 0.64 X | |||
| Total Debt | 255 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 1.71 X | |||
| Book Value Per Share | 0.19 X | |||
| Cash Flow From Operations | (28.01 M) | |||
| Short Ratio | 11.46 X | |||
| Earnings Per Share | (1.47) X | |||
| Target Price | 8.52 | |||
| Number Of Employees | 35 | |||
| Beta | 1.69 | |||
| Market Capitalization | 14.24 M | |||
| Total Asset | 19.72 M | |||
| Retained Earnings | (349.95 M) | |||
| Working Capital | 4.4 M | |||
| Current Asset | 118.86 M | |||
| Current Liabilities | 12.48 M | |||
| Z Score | 5.77 | |||
| Net Asset | 19.72 M |
About Celyad SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Celyad SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celyad SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celyad SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Celyad Stock
If you are still planning to invest in Celyad SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celyad SA's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |